Abstract
Posterior reversible encephalopathy syndrome (PRES) encompasses a spectrum of imaging manifestations associated with acute encephalopathy and definite predisposing factors (hypertension, pregnancy, pathological conditions, and drugs). Although PRES was named after the first radiology reports with classic imaging presentations, not all cases of PRES are posterior or reversible. It is now clear that PRES shares imaging and pathogenic similarities with other conditions (e.g., reversible cerebral vasoconstriction syndrome, RCVS), that may represent a disease continuum rather than separate entities. Consistent medical history and clinical neuroradiology findings (vasogenic edema in typical locations) are crucial elements for diagnosis. Overall, PRES is a relatively benign condition that generally resolves after the treatment of the underpinning factors.
Abbreviations
- ADC:
-
Apparent Diffusion Coefficient
- ARIA:
-
Amyloid-Related Imaging Abnormalities
- ASL:
-
Arterial Spin Labeling
- CAAri:
-
Cerebral Amyloid Angiopathy-related inflammation
- CT:
-
Computed Tomography
- DSC:
-
Dynamic Susceptibility Contrast
- DWI:
-
Diffusion-Weighted Imaging
- FFE T2*:
-
Fast Field Echo T2*
- FLAIR:
-
Fluid-Attenuated Inversion Recovery
- Gad:
-
Gadolinium
- HMPAO:
-
Hexa-Methyl-Propylene-Amine Oxime
- HUS:
-
Hemolytic Uremic Syndrome
- IFN-alpha:
-
Interferon-alpha
- IVIg:
-
Intravenous Immunoglobulins
- MRA:
-
Magnetic Resonance Angiography
- MRI:
-
Magnetic Resonance Imaging
- MTT:
-
Mean Transit Time
- NECT:
-
Non-enhanced CT
- PAN:
-
Polyarteritis Nodosa
- PCNSV:
-
Primary Central Nervous System Vasculitis
- PRES:
-
Posterior Reversible Encephalopathy Syndrome
- PRES-SCI:
-
Spinal Cord Involvement in PRES
- rCBF:
-
Regional Cerebral Blood Flow
- rCBV:
-
Regional Cerebral Blood Volume
- RCVS:
-
Reversible Cerebral Vasoconstriction Syndrome
- SPECT:
-
Single-Photon Emission Computed Tomography
- SWI:
-
Susceptibility-Weighted Imaging
- Tc99m:
-
Technetium-99
- TOF:
-
Time of Flight
- TTP:
-
Thrombotic Thrombocytopenic Purpura
References
Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical. Am J Neuroradiol. 2008a;29:1036–42.
Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol. 2008b;29:1043–9.
Schiff D, Lopes M-B. Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care. 2005;2(3):303–5.
Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol. 2007;28:1320–7.
Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy. Am J Neuroradiol. 2008;29:447–55.
Hamilton BE, Nesbit GM. Delayed CSF enhancement in posterior reversible encephalopathy syndrome. Am J Neuroradiol. 2008;29:456–7.
Roth C, Ferbert A. Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry. 2010;81:773–7.
Shankar J, Banfield J. Posterior reversible encephalopathy syndrome: a review. Can Assoc Radiol J. 2017;68:147–53.
Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and Vasogenic edema in eclampsia. Am J Neuroradiol. 2001;22(July):1068–70.
Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol. 2002;23(July):1038–48.
Brubaker LM, Smith JK, Lee YZ, Lin W, Castillo M. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. Am J Neuroradiol. 2005;26(April):825–30.
Kitagouchi H, Tomimoto H, Miki Y, Yamamoto A, Terada K, Satoi H, Kanda M, Fukuyama H. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2005;47:652–6. https://doi.org/10.1007/s00234-005-1399-z.
Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns. Am J Neuroradiol. 2008 Sep;29(8):1428–35.
Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical. Am J Neuroradiol. 2009;30:1371–9.
de Havenon A, Joos Z, Longenecker L. Posterior reversible encephalopathy syndrome with spinal cord involvement. Neurology. 2014;83:2002–6.
Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E, et al. Posterior reversible encephalopathy syndrome — insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2015;14(9):830–6.
Karia SJ, Rykken JB, McKinney ZJ, Zhang L, McKinney AM. Utility and significance of gadolinium-based contrast enhancement in posterior reversible encephalopathy syndrome. Am J Neuroradiol. 2016;37:415–22.
Marrone LCP, Martins WA, Brunelli JPF, Fussiger H, Carvalhal GF, Filho JRH, et al. PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know? Spinal Cord Ser Cases. 2016;2:15001.
Ollivier M, Bertrand A, Clarençon F, Gerber S, Deltour S, Domont F, et al. Neuroimaging features in posterior reversible encephalopathy syndrome: a pictorial review. J Neurol Sci. 2017;373:188–200.
Further Reading
Stevens CJ, Heran MKS. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol. 2012;85(December):1566–75.
Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, Sepsis, and shock. Am J Neuroradiol. 2006;27:2179–90.
Karakis I, Macdonald JA, Stefanidiou M, Clinical KCS. Radiological features of brainstem variant of hypertensive encephalopathy. J Vasc Interv Neurol. 2009;2(2):172–6.
Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85(2):427–32.
Gao B, Yu BX, Li RS, Zhang G, Xie HZ, Liu FL, Lv C. Cytotoxic edema in posterior reversible encephalopathy syndrome: correlation of MRI features with serum albumin levels. Am J Neuroradiol. 2015;36:1886–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this entry
Cite this entry
Godi, C., Falini, A. (2018). Posterior Reversible Encephalopathy Syndrome (PRES). In: Barkhof, F., Jager, R., Thurnher, M., Rovira Cañellas, A. (eds) Clinical Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-319-61423-6_83-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-61423-6_83-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61423-6
Online ISBN: 978-3-319-61423-6
eBook Packages: Springer Reference MedicineReference Module Medicine